Vaccines and vaccination in prison settings: availability and model of service delivery in 20 European countries.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
05 Oct 2024
Historique:
received: 09 07 2024
accepted: 26 09 2024
medline: 6 10 2024
pubmed: 6 10 2024
entrez: 5 10 2024
Statut: epublish

Résumé

Prisons, due to various risk factors, are environments that are conducive to infectious disease transmission, with significantly higher prevalence of infectious diseases within prisons compared to the general population. This underscores the importance of preventive measures, particularly vaccination. As part of the international project "Reaching the hard-to-reach: Increasing access and vaccine uptake among the prison population in Europe" (RISE-Vac), this study aimed to map the availability and delivery framework of vaccination services in prisons across Europe and beyond. A questionnaire designed to collect data on the availability and delivery model of vaccination services in prisons was validated and uploaded in SurveyMonkey in July 2023. Then, it was submitted to potential participants, with at least one representative from each European country. Potential participants emailed an invitation letter by the RISE-Vac partners and by the European Organization of Prison and Correctional Services (EUROPRIS). Twenty European countries responded. Vaccines are available in European countries, although their availability differs by country and type of vaccine. The first dose is offered to people living in prisons (PLP), mostly within one month, COVID-19 is the most widely offered vaccine. In all countries, vaccines are actively offered by healthcare workers; in most countries, there is no evaluation of vaccination status among people who work in prison. The survey shows variance in vaccine availability for PLP and staff across countries and vaccine types. Quality healthcare in prisons is not only a matter of the right to health but also a critical public health investment: enhancing vaccine uptake consistently among PLP and staff should be prioritized.

Identifiants

pubmed: 39369203
doi: 10.1186/s12889-024-20207-3
pii: 10.1186/s12889-024-20207-3
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2716

Subventions

Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353
Organisme : European Union's 3rd Health Program (2014-2020)
ID : 101018353

Informations de copyright

© 2024. The Author(s).

Références

MacDonald M. Overcrowding and its impact on prison conditions and health. Int J Prison Health. 2018;14(2):65–8.
doi: 10.1108/IJPH-04-2018-0014 pubmed: 29869586
Moazen B, Saeedi Moghaddam S, Silbernagl MA, Lotfizadeh M, Bosworth RJ, Alammehrjerdi Z, Kinner SA, Wirtz AL, Bärnighausen TW, Stöver HJ, Dolan KA. Prevalence of drug injection, sexual activity, tattooing, and piercing among prison inmates. Epidemiol Rev. 2018;40(1):58–69.
doi: 10.1093/epirev/mxy002 pubmed: 29860343
Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, El-Bassel N, Dolan K, Moazen B, Wirtz AL, Verster A, Altice FL. Prevention of transmission of HIV, Hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. Lancet. 2016;388(10049):1115–26.
doi: 10.1016/S0140-6736(16)30769-3 pubmed: 27427456
Marquez N, Ward JA, Parish K, Saloner B, Dolovich S. COVID-19 incidence and mortality in federal and state prisons compared with the US Population, April 5, 2020, to April 3, 2021. JAMA. 2021;326(18):1865–7.
doi: 10.1001/jama.2021.17575 pmcid: 8495600 pubmed: 34613335
Moazen B, Agbaria N, Ismail N, Mazzilli S, Klankwarth UB, Amaya A, Rosello A, D’Arcy J, Plugge E, Stöver H, Tavoschi L. Interventions to increase vaccine uptake among people who live and work in prisons: a global multistage scoping review. J Community Psychol. 2023;1–17. https://doi.org/10.1002/jcop.23077 .
Moazen B, Ismail N, Agbaria N, Mazzilli S, Petri D, Amaya A, D’Arcy J, Plugge E, Tavoschi L, Stöver H. Vaccination against emerging and reemerging infectious diseases in places of detention: a global multistage scoping review. Front Public Health. 2024;12:1323195.
doi: 10.3389/fpubh.2024.1323195 pmcid: 10859397 pubmed: 38347924
Madeddu G, Vroling H, Oordt-Speets A, Babudieri S, O’Moore É, Noordegraaf MV, Monarca R, Lopalco PL, Hedrich D, Tavoschi L. Vaccinations in prison settings: a systematic review to assess the situation in EU/EEA countries and in other high income countries. Vaccine. 2019;37(35):4906–19.
doi: 10.1016/j.vaccine.2019.07.014 pubmed: 31327651
Allison M, Musser B, Satterwhite C, Ault K, Kelly P, Ramaswamy M. Human papillomavirus vaccine knowledge and intention among adult inmates in Kansas, 2016–2017. Am J Public Health. 2018;108(8):1000–2.
doi: 10.2105/AJPH.2018.304499 pmcid: 6050866 pubmed: 29927651
Berk J, Murphy M, Kane K, Chan P, Rich J, Brinkley-Rubinstein L. Initial SARS-CoV-2 Vaccination Uptake in a correctional Setting: cross-sectional study. JMIRx Med. 2021;2(3):e30176.
doi: 10.2196/30176 pmcid: 8483152 pubmed: 34658368
Emerson A, Allison M, Kelly PJ, Ramaswamy M. Barriers and facilitators of implementing a collaborative HPV vaccine program in an incarcerated population: a case study. Vaccine. 2020;38(11):2566–71.
doi: 10.1016/j.vaccine.2020.01.086 pmcid: 7133786 pubmed: 32046888
Fair H, Walmsley R. World prison population list fourteenth edition. May 2024. Available from: https://www.prisonstudies.org/sites/default/files/resources/downloads/world_prison_population_list_14th_edition.pdf . Access 20 Jun 2024.
Allison M, Emerson A, Pickett ML, Ramaswamy M. Incarcerated adolescents’ attitudes toward Human Papillomavirus Vaccine: Report from a Juvenile Facility in Kansas. Glob Pediatr Health. 2019;6:2333794X19855290.
doi: 10.1177/2333794X19855290 pmcid: 6572877 pubmed: 31236433
Goldman PN, Szoko N, Lynch L, Rankine J. Vaccination for justice-involved youth. Pediatrics. 2022;149(4):e2021055394.
doi: 10.1542/peds.2021-055394 pubmed: 35318482
Junghans C, Heffernan C, Valli A, Gibson K. Mass vaccination response to a measles outbreak is not always possible. Lessons from a London prison. Epidemiol Infect. 2018;146(13):1689–91.
doi: 10.1017/S0950268818001991 pmcid: 9507953 pubmed: 30021664
Couper S, Bird SM, Foster GR, McMenamin J. Opportunities for protecting prisoner health: influenza vaccination as a case study. Public Health. 2013;127(3):295–6.
doi: 10.1016/j.puhe.2012.12.004 pubmed: 23433576
United Nations General Assembly. United Nations standard minimum rules for the treatment of prisoners (the Nelson Mandela Rules). Available at: https://www.unodc.org/documents/justice-and-prison-reform/Nelson_Mandela_Rules-E-ebook.pdf . Access 14 Nov 2022.
McLeod KE, Butler A, Young JT, Southalan L, Borschmann R, Sturup-Toft S, Dirkzwager A, Dolan K, Acheampong LK, Topp SM, Martin RE, Kinner SA. Global Prison health care governance and health equity: a critical lack of evidence. Am J Public Health. 2020;110(3):303–8.
doi: 10.2105/AJPH.2019.305465 pmcid: 7002953 pubmed: 31944844
Patient or prisoner: does it matter which Government Ministry is responsible for the health of prisoners? Available from: https://www.euro.who.int/__data/assets/pdf_file/0014/126410/e94423.pdf . Access 14 Nov 2022.
WHO Europe. Good governance for prison health in the 21st century: a policy brief on the organization of prison health. 2013. Available from: https://www.euro.who.int/__data/assets/pdf_file/0017/231506/Good-governance-for-prison-health-in-the-21st-century.pdf . Access 14 Nov 2022.
Moazen B, Assari S, Neuhann F, Stöver H. The guidelines on infection control in prisons need revising. Lancet. 2019;394(10195):301–2.
doi: 10.1016/S0140-6736(19)30279-X pubmed: 31354141
Kinner SA, Young JT, Snow K, Southalan L, Lopez-Acuña D, Ferreira-Borges C, O’Moore É. Prisons and custodial settings are part of a comprehensive response to COVID-19. Lancet Public Health. 2020;5(4):e188-9.
doi: 10.1016/S2468-2667(20)30058-X pmcid: 7103922 pubmed: 32197116
Burki T. Prisons are in no way equipped to deal with COVID-19. Lancet. 2020;395(10234):1411–2.
doi: 10.1016/S0140-6736(20)30984-3 pmcid: 7252088 pubmed: 32359457
Penal Reform International and Harm Reduction International. COVID-19 vaccinations for prison populations and staff: Report on global scan. 2021. Available from: https://cdn.penalreform.org/wp-content/uploads/2021/12/HRI-PRI_CovidVaccinationReport_Dec2021.pdf . Access 14 Nov 2022.

Auteurs

Babak Moazen (B)

Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt/Main, Germany.
Present address: Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.

Maria Tramonti Fantozzi (M)

Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Via Savi 10, Pisa, PI, 56126, Italy.

Erica De Vita (E)

Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Via Savi 10, Pisa, PI, 56126, Italy. erica.devita@unipi.it.

Davide Petri (D)

Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Via Savi 10, Pisa, PI, 56126, Italy.
Department of Environment and Health, National Health Institute, Rome, Italy.

Irina Barbîroș (I)

National Administration of Penitentiaries, Chișinău, Republic of Moldova.

Vlad Busmachiu (V)

National Administration of Penitentiaries, Chișinău, Republic of Moldova.

Roberto Ranieri (R)

Infectious Diseases Service, Penitentiary Health System, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo [Saints Paul and Charles Local Health Authority], Milan, Italy.

Nicola Cocco (N)

Infectious Diseases Service, Penitentiary Health System, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo [Saints Paul and Charles Local Health Authority], Milan, Italy.

Aurélie Mieuset (A)

Health Unit of the Villeneuve-les-Maguelone Prison, University Hospital Centre Montpellier, Montpellier, France.

Fadi Meroueh (F)

Health Unit of the Villeneuve-les-Maguelone Prison, University Hospital Centre Montpellier, Montpellier, France.

Laura Baglietto (L)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Heino Stöver (H)

Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt/Main, Germany.

Lara Tavoschi (L)

Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Via Savi 10, Pisa, PI, 56126, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH